Results
Nectar Lifesciences FY26 Net Loss ₹292.89 Crore
Nectar Lifesciences reported a consolidated net loss of ₹292.89 crore for FY 2025-26, driven by discontinued operations and investment losses.
The Board approved audited standalone and consolidated fi
